Skip to main content
MedPathMedPath Home
Clinical Trials/IRCT20220406054431N1
IRCT20220406054431N1
Recruiting
Phase 2

Determining the efficacy of quadruple standard regimen combined with simvastatin, probiotic, and NAC as adjuvant therapy for H. Pylori eradication and comparing to standard treatment

Shahid Beheshti University of Medical Sciences0 sites168 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHelicobacter pylori infection.Helicobacter pylori [H. pylori] as the cause of diseases classified elsewhereB96.81

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Helicobacter pylori infection.
Sponsor
Shahid Beheshti University of Medical Sciences
Enrollment
168
Status
Recruiting
Last Updated
3 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •People over the age of 18 and under 65
  • •With positive stool antigen test or endoscopy for Helicobacter pylori

Exclusion Criteria

  • •History of heart, kidney and liver failure
  • •Developing an active cancer
  • •Drug and alcohol addiction
  • •Recent history of gastrointestinal bleeding
  • •Get previous treatment

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Phase 2
Investigating the effect of furazolidone drug for the treatment of stomach bacterial infectioH. pylori infection.Helicobacter pylori [H. pylori] as the cause of diseases classified elsewhereB96.81
IRCT20230202057305N1Shahid Beheshti University of Medical Sciences135
Not yet recruiting
Not Applicable
Comparison of the efficacy of different treatment regimen for treating stomach infection by Helicobacter pylori.
CTRI/2020/04/024929AIIMS BHUBANESWAR
Not yet recruiting
Phase 2
Evaluation and comparison of the efficacy of triple therapies regimens containing esomeprazole and different doses of amoxicillin and bismuth for eradicating Helicobacter pylori infection in Sari
IRCT20210518051335N1Mazandaran University of Medical Sciences200
Not yet recruiting
Phase 3
Comparative Evaluation Of The Efficacy Of Standard Market Preparation Tablet And Swayamguptadi Vati In The Management Of Klaibya (Erectile Dysfunction)Health Condition 1: N528- Other male erectile dysfunction
CTRI/2024/05/066866Mahatma Gandhi Ayurved College Hospital and Center
Not yet recruiting
Phase 3
Effect of Vrishya Gutika In The Management Of Klaibya (Erectile Dysfunction)Health Condition 1: N528- Other male erectile dysfunction
CTRI/2023/01/048777Mahatma Gandhi Ayurved College Hospital and Center